Kayne Anderson Rudnick Investment Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$65.9M Sell
71,696
-10,234
-12% -$10.4M 0.19% 110
2025
Q4
$88M Sell
81,930
-12,625
-13% -$12.1M 0.24% 106
2025
Q3
$72.1M Buy
94,555
+10,609
+13% +$7.89M 0.18% 115
2025
Q2
$65.4M Buy
83,946
+6,785
+9% +$5.27M 0.16% 120
2025
Q1
$63.7M Sell
77,161
-4,587
-6% -$3.82M 0.16% 123
2024
Q4
$63.1M Sell
81,748
-2,987
-4% -$2.47M 0.15% 125
2024
Q3
$75.1M Sell
84,735
-1,227
-1% -$1.1M 0.17% 115
2024
Q2
$77.8M Sell
85,962
-3,466
-4% -$2.77M 0.19% 114
2024
Q1
$69.6M Sell
89,428
-1,921
-2% -$1.37M 0.16% 124
2023
Q4
$53.2M Sell
91,349
-2,809
-3% -$1.64M 0.13% 132
2023
Q3
$50.6M Sell
94,158
-3,141
-3% -$1.62M 0.14% 129
2023
Q2
$45.6M Buy
97,299
+31,671
+48% +$13.3M 0.13% 134
2023
Q1
$22.5M Sell
65,628
-2,002
-3% -$675K 0.07% 178
2022
Q4
$24.7M Buy
67,630
+35,587
+111% +$12.6M 0.08% 173
2022
Q3
$10.4M Buy
32,043
+29,879
+1,381% +$9.47M 0.03% 245
2022
Q2
$702K Sell
2,164
-122
-5% -$36.6K ﹤0.01% 361
2022
Q1
$655K Buy
2,286
+328
+17% +$84.4K ﹤0.01% 360
2021
Q4
$541K Buy
1,958
+11
+0.6% +$2.79K ﹤0.01% 369
2021
Q3
$450K Buy
1,947
+55
+3% +$13.6K ﹤0.01% 367
2021
Q2
$434K Sell
1,892
-200
-10% -$40.2K ﹤0.01% 365
2021
Q1
$391K Hold
2,092
﹤0.01% 366
2020
Q4
$353K Hold
2,092
﹤0.01% 364
2020
Q3
$310K Buy
2,092
+1,406
+205% +$218K ﹤0.01% 358
2020
Q2
$113K Buy
686
+200
+41% +$30.7K ﹤0.01% 375
2020
Q1
$67K Hold
486
﹤0.01% 381
2019
Q4
$64K Hold
486
﹤0.01% 378
2019
Q3
$54K Hold
486
﹤0.01% 370
2019
Q2
$54K Buy
+486
New +$57.2K ﹤0.01% 365

Other funds holding LLY

Kayne Anderson Rudnick Investment Management's LLY Position: Q1 2026 in Review

Kayne Anderson Rudnick Investment Management reduced its Eli Lilly (LLY) stake by 12% in Q1 2026, selling an estimated $10.4M and leaving 71,696 shares worth $65.9M. The position accounts for 0.19% of the portfolio, ranked #110.

Kayne Anderson Rudnick Investment Management first reported a position in LLY in Q2 2019 and has held it in 28 quarters since. The position peaked at $88M in Q4 2025. 4,364 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Kayne Anderson Rudnick Investment Management held 71,696 shares of Eli Lilly worth $65.9M as of Q1 2026.
  • Kayne Anderson Rudnick Investment Management sold 10,234 Eli Lilly shares in Q1 2026, an estimated $10.4M.
  • Eli Lilly made up 0.19% of Kayne Anderson Rudnick Investment Management's portfolio in Q1 2026, its #110 holding.
  • Kayne Anderson Rudnick Investment Management first reported a position in Eli Lilly in Q2 2019 and has held it in 28 quarters since.
  • Kayne Anderson Rudnick Investment Management's Eli Lilly position peaked at $88M in Q4 2025.
  • 4,364 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q1 2026, filed 14 May 2026.